Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 53.85% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 10.67% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -4.92% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 11.80% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 6.67% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 22.20% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -9.72% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -17.81% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 6.42% |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | 30.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.02% |
| Dec 31, 2025 | 44.49% |
| Sep 30, 2025 | 15.78% |
| Jun 30, 2025 | 30.57% |
| Mar 31, 2025 | 13.16% |
| Dec 31, 2024 | 3.10% |
| Sep 30, 2024 | -25.99% |
| Jun 30, 2024 | -53.72% |
| Mar 31, 2024 | -49.88% |
| Dec 31, 2023 | -81.52% |
| Sep 30, 2023 | -80.89% |
| Jun 30, 2023 | -62.63% |
| Mar 31, 2023 | -58.51% |
| Dec 31, 2022 | 53.61% |
| Sep 30, 2022 | 71.95% |
| Jun 30, 2022 | 11.82% |
| Mar 31, 2022 | 55.81% |
| Dec 31, 2021 | 73.10% |
| Sep 30, 2021 | 3.70% |
| Jun 30, 2021 | 46.66% |